Capricor Therapeutics increases authorized common shares from 50M to 100M

CAPRICOR THERAPEUTICS, INC.

Stockholders approved amendment at May 14, 2024 annual meeting.
Certificate of Amendment filed with Delaware on May 15, 2024, effective same day.
Authorized common stock increased to 100 million shares (previously 50 million).

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CAPRICOR THERAPEUTICS, INC.: Increased authorized common stock from 50,000,000 to 100,000,000 shares (effective 2024-05-15).

Change: charter amendment
Effective: 2024-05-15

Exact text from the filing

the stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock from 50,000,000 to 100,000,000. On May 15, 2024, the Company filed a Certificate of Amendment of Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect the Amendment, effective as of May 15, 2024.

View on SEC.gov

190 governance changes filed in the last 30 days. Browse all governance changes →

CAPRICOR THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001558370-24-008313

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.